中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
4-氟-N-(2-[4-(2-甲氧苯基)1-哌嗪基]乙基)-N-(2-吡啶基)苯酰胺二盐酸 | 4-fluoro-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-pyridin-2-ylbenzylamide | 155204-26-5 | C25H27FN4O2 | 434.513 |
4-碘-N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶苯胺 | 4-iodo-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-pyridin-2-ylbenzylamide | 155204-23-2 | C25H27IN4O2 | 542.419 |
—— | p-MPPNO2 | 155204-27-6 | C25H27N5O4 | 461.52 |
4-(2-甲氧基苯基)-N-2-吡啶基-1-哌嗪乙酰胺 | 4-(2-methoxyphenyl)-1-(2-pyridinylaminocarbonyl)methylpiperazine | 146714-63-8 | C18H22N4O2 | 326.398 |
—— | 1-(2-methoxyphenyl)-4-(2-(2-pyridylamino)ethyl)piperazine | 155204-28-7 | C18H24N4O | 312.415 |
Green strategies for late-stage fluorination with 18F, in which ethanol and water are the only solvents used throughout the entire radiolabeling process, have been developed and applied to the radiosyntheses of a range of radiopharmaceuticals commonly employed in clinical PET imaging.